These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 18586466)

  • 1. Genetic characterization of human Dsg3-specific B cells isolated by flow cytometry from the peripheral blood of patients with pemphigus vulgaris.
    Yamagami J; Takahashi H; Ota T; Amagai M
    J Dermatol Sci; 2008 Nov; 52(2):98-107. PubMed ID: 18586466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A mouse model of pemphigus vulgaris by adoptive transfer of naive splenocytes from desmoglein 3 knockout mice.
    Aoki-Ota M; Tsunoda K; Ota T; Iwasaki T; Koyasu S; Amagai M; Nishikawa T
    Br J Dermatol; 2004 Aug; 151(2):346-54. PubMed ID: 15327541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Desmoglein 1 and 3 enzyme-linked immunosorbent assay in Iranian patients with pemphigus vulgaris: correlation with phenotype, severity, and disease activity.
    Daneshpazhooh M; Chams-Davatchi C; Khamesipour A; Mansoori P; Taheri A; Firooz A; Mortazavi H; Esmaili N; Dowlati Y
    J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1319-24. PubMed ID: 17958835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conformational epitope mapping of antibodies against desmoglein 3 in experimental murine pemphigus vulgaris.
    Anzai H; Fujii Y; Nishifuji K; Aoki-Ota M; Ota T; Amagai M; Nishikawa T
    J Dermatol Sci; 2004 Aug; 35(2):133-42. PubMed ID: 15265525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Confirmation of a disease model of pemphigus vulgaris: characterization and correlation between disease parameters in 90 mice.
    Holm TL; Markholst H
    Exp Dermatol; 2010 Aug; 19(8):e158-65. PubMed ID: 20201956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dissecting the anti-desmoglein autoreactive B cell repertoire in pemphigus vulgaris patients.
    Qian Y; Diaz LA; Ye J; Clarke SH
    J Immunol; 2007 May; 178(9):5982-90. PubMed ID: 17442983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pemphigus mouse model as a tool to evaluate various immunosuppressive therapies.
    Takae Y; Nishikawa T; Amagai M
    Exp Dermatol; 2009 Mar; 18(3):252-60. PubMed ID: 18643850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical activity of pemphigus vulgaris relates to IgE autoantibodies against desmoglein 3.
    Nagel A; Lang A; Engel D; Podstawa E; Hunzelmann N; de Pita O; Borradori L; Uter W; Hertl M
    Clin Immunol; 2010 Mar; 134(3):320-30. PubMed ID: 20015693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Auto-reactive B cells against peripheral antigen, desmoglein 3, escape from tolerance mechanism.
    Ota T; Aoki-Ota M; Tsunoda K; Simoda K; Nishikawa T; Amagai M; Koyasu S
    Int Immunol; 2004 Oct; 16(10):1487-95. PubMed ID: 15339881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenic IgG antibodies against desmoglein 3 in pemphigus vulgaris are regulated by HLA-DRB1*04:02-restricted T cells.
    Eming R; Hennerici T; Bäcklund J; Feliciani C; Visconti KC; Willenborg S; Wohde J; Holmdahl R; Sønderstrup G; Hertl M
    J Immunol; 2014 Nov; 193(9):4391-9. PubMed ID: 25252957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum from pemphigus vulgaris reduces desmoglein 3 half-life and perturbs its de novo assembly to desmosomal sites in cultured keratinocytes.
    Cirillo N; Femiano F; Gombos F; Lanza A
    FEBS Lett; 2006 May; 580(13):3276-81. PubMed ID: 16698018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intraperitoneal injection of pemphigus vulgaris-IgG into mouse depletes epidermal keratinocytes of desmoglein 3 associated with generation of acantholysis.
    Shu E; Yamamoto Y; Aoyama Y; Kitajima Y
    Arch Dermatol Res; 2007 Jun; 299(3):165-7. PubMed ID: 17431647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultrastructural changes in mice actively producing antibodies to desmoglein 3 parallel those in patients with pemphigus vulgaris.
    Shimizu A; Ishiko A; Ota T; Tsunoda K; Koyasu S; Amagai M; Nishikawa T
    Arch Dermatol Res; 2002 Oct; 294(7):318-23. PubMed ID: 12373337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-dose pemphigus antibodies against linear epitopes of desmoglein 3 (Dsg3) can induce acantholysis and depletion of Dsg3 from keratinocytes.
    Cirillo N; Femiano F; Gombos F; Lanza A
    Immunol Lett; 2009 Feb; 122(2):208-13. PubMed ID: 19200441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IgG reactivity against non-conformational NH-terminal epitopes of the desmoglein 3 ectodomain relates to clinical activity and phenotype of pemphigus vulgaris.
    Müller R; Svoboda V; Wenzel E; Gebert S; Hunzelmann N; Müller HH; Hertl M
    Exp Dermatol; 2006 Aug; 15(8):606-14. PubMed ID: 16842599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subcellular localization of desmosomal components is different between desmoglein3 knockout mice and pemphigus vulgaris model mice.
    Saito H; Shimizu A; Tsunoda K; Amagai M; Ishiko A
    J Dermatol Sci; 2009 Aug; 55(2):108-15. PubMed ID: 19525093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coexistence of IgA antibodies to desmogleins 1 and 3 in pemphigus vulgaris, pemphigus foliaceus and paraneoplastic pemphigus.
    Mentink LF; de Jong MC; Kloosterhuis GJ; Zuiderveen J; Jonkman MF; Pas HH
    Br J Dermatol; 2007 Apr; 156(4):635-41. PubMed ID: 17263817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aire-dependent thymic expression of desmoglein 3, the autoantigen in pemphigus vulgaris, and its role in T-cell tolerance.
    Wada N; Nishifuji K; Yamada T; Kudoh J; Shimizu N; Matsumoto M; Peltonen L; Nagafuchi S; Amagai M
    J Invest Dermatol; 2011 Feb; 131(2):410-7. PubMed ID: 21048786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IgG against extracellular subdomains of desmoglein 3 relates to clinical phenotype of pemphigus vulgaris.
    Müller R; Svoboda V; Wenzel E; Müller HH; Hertl M
    Exp Dermatol; 2008 Jan; 17(1):35-43. PubMed ID: 18095943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoreactive B-cell elimination by pathogenic IgG specific for the same antigen: implications for peripheral tolerance.
    Ota T; Aoki-Ota M; Tsunoda K; Nishikawa T; Koyasu S; Amagai M
    Int Immunol; 2008 Oct; 20(10):1351-60. PubMed ID: 18765425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.